Web Stats Provided By Google Analytics

Thursday, May 21, 2015

Regeneron and Sanofi Partnership Records Another Hit In Latest String of Successes

May 21, 2015 By Mark Terry and Riley McDermid , BioSpace.com Breaking News Staff Tarrytown, N.Y.-based Regeneron Pharmaceuticals, Inc. announced today that its Phase III trial of sarilumab for rheumatoid arthritis met its co-primary efficacy endpoints. This is just the most recent in a string of successes for Regeneron and its partnership with Paris-based Sanofi .
http://ift.tt/1EZL1qP

No comments:

Post a Comment

Popular Tarrytown Roundup Posts